| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 118, 1-6, Copyright © 1985 by American Society for Investigative Pathology
REGULAR ARTICLES |
GS Pinkus and JW Said
Using monoclonal antibodies to leukocyte common antigen, granulocyte- related antigen, and B-cell specific antigens, L&H variants of Reed- Sternberg (R-S) cells in Hodgkin's disease, lymphocyte predominance type (nodular), exhibited a unique staining profile as compared with R- S cells of other histologic types. L&H variants were strongly immunoreactive for leukocyte common antigen, as defined by monoclonal antibodies PD6/27 and 2B11; whereas other types of R-S cells were negative or rarely positive. R-S cells and variants in 69 cases of Hodgkin's disease of nodular sclerosis (41), mixed cellularity (25) or lymphocyte depletion (3) types, were consistently strongly immunoreactive for Leu-M1, a granulocyte-related antigen, while L&H variants were uniformly nonreactive (4 cases). B-cell specific antigens, detected by three pan-B-cell monoclonal antibodies, were observed only for L&H variants. These observations suggest that L&H variants of R-S cells represent a distinct type of transformed cell, possibly of B-cell origin, and do not share a common lineage with other types of R-S cells. These studies provide further evidence that Hodgkin's disease, lymphocyte predominance type, nodular, may represent a distinct entity.
This article has been cited by other articles:
![]() |
I. Anagnostopoulos, M.-L. Hansmann, K. Franssila, M. Harris, N. L. Harris, E. S. Jaffe, J. Han, J. M. van Krieken, S. Poppema, T. Marafioti, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes Blood, September 1, 2000; 96(5): 1889 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Aster Lymphocyte-Predominant Hodgkin's Disease: How Little Therapy Is Enough? J. Clin. Oncol., March 1, 1999; 17(3): 744 - 744. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |